Gut microbiota: Firmicutes and Bacteroidetes involved in insulin resistance by mediating levels of glucagon-like peptide 1

Nature Reviews Endocrinology

Volumn 11, Issue 5, 2015, Pages 254-

  Greenhill, Claire ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN ZINC; GLUCAGON LIKE PEPTIDE 1; INSULIN; RNA 16S; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTEROIDETES; DIET INDUCED OBESITY; ENERGY METABOLISM; FIRMICUTES; GENE SEQUENCE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HORMONE RELEASE; HYPERINSULINEMIA; IMMUNE RESPONSE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; LIPID DIET; NONHUMAN; NOTE; PRIORITY JOURNAL; PYROSEQUENCING; ANIMAL; DRUG EFFECTS; GASTROINTESTINAL TRACT; HUMAN; METABOLISM; MICROBIOLOGY; MICROFLORA; OBESITY;

ANIMALS; ANTI-BACTERIAL AGENTS; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN RESISTANCE; MICROBIOTA; OBESITY;

EID: 84929952666     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2015.40     Document Type: Note

References (1)

1. Hwang, I. et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. doi:10.1096/fj.14-265983